O'Day Daniel Patrick
SEC Form 4 history across 1 companies, 8 transactions and 3 filings.
Available history · Sep 01, 2026 – Oct 01, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$445kView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$1.77MView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | M · exerciseDerivative securitySEC filing ↗ | UnknownView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | F · withholdingSEC filing ↗ | -$612kView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | M · exerciseSEC filing ↗ | UnknownView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$807kView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$1.18MView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$236kView disclosure → |
Latest Form 4 facts
Quick context from source filings
sale at GILEAD SCIENCES, INC. on Oct 01, 2026 valued at $445,880.
Review SEC filingNo open-market insider purchase is available.
Monthly open-market activity
Last 2 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Sep 2026 | 0 | 3 | $0.00 | $2,229,592.04 | -$2,229,592.04 |
| Oct 2026 | 0 | 2 | $0.00 | $2,218,507.50 | -$2,218,507.50 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
7 observations · Sep 1, 2026 – Oct 1, 2026. Window ends at the latest available report, not today.
View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Sep 1, 2026 | 590,533 | Sep 2, 2026 | View transaction |
| Sep 1, 2026 | 582,541 | Sep 2, 2026 | View transaction |
| Sep 1, 2026 | 577,133 | Sep 2, 2026 | View transaction |
| Sep 10, 2026 | 585,913 | Sep 11, 2026 | View transaction |
| Sep 10, 2026 | 581,683 | Sep 11, 2026 | View transaction |
| Oct 1, 2026 | 569,683 | Oct 2, 2026 | View transaction |
| Oct 1, 2026 | 566,683 | Oct 2, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
O'Day Daniel Patrick Insider Activity FAQ
SEC Form 4 context
Who is O'Day Daniel Patrick?
O'Day Daniel Patrick is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001638643.
Which companies has O'Day Daniel Patrick reported transactions for?
GILEAD SCIENCES, INC.
When was O'Day Daniel Patrick's latest insider buy?
No open-market insider purchase is available for this period.
When was O'Day Daniel Patrick's latest insider sale?
sale at GILEAD SCIENCES, INC. on Oct 01, 2026 valued at $445,880.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.